Skip to content
  • Media
  • Investors
  • Media
  • Investors
  • TAMP Therapy Platform
    • Our Science
    • RenovoCath®
  • Physicians
    • Evidence
    • Resources
  • Patients
    • The Procedure
    • FAQs
    • Patient Stories
    • Physician Locator
  • About Us
    • Overview & Leadership
    • Board of Directors
    • Advisory Boards
  • Contact
  • Media
  • Investors
  • TAMP Therapy Platform
    • Our Science
    • RenovoCath®
  • Physicians
    • Evidence
    • Resources
  • Patients
    • The Procedure
    • FAQs
    • Patient Stories
    • Physician Locator
  • About Us
    • Overview & Leadership
    • Board of Directors
    • Advisory Boards
  • Contact
  • Media
  • Investors

Day: October 12, 2026

New Cancer Tech Sends Chemo Straight To Tumors

A targeted drug-delivery device may help some pancreatic cancer patients get chemotherapy with fewer body-wide side effects.

New Device Delivers Targeted Chemo for Pancreatic Cancer, Offering Fresh Hope

For 70-year-old Roberta Luna, tending to her garden is therapy — especially trimming rosemary, its purple blooms matching the color she wears every day for pancreatic cancer awareness: purple.

Jersey Shore Hospital Offering New Treatment to Target Pancreatic Cancer

Pancreatic cancer is a disease that’s often deadly, but a new treatment is showing promise at a New Jersey hospital. NBC10’s Ted Greenberg explains how it has made a difference for one man who thought he was out of options.

Moffitt Using New Approach to Treat Pancreatic Cancer

When 83-year-old Richard Martin was diagnosed with pancreatic cancer in 2024, he underwent 22 rounds of chemotherapy followed by radiation.

Doctors Testing ‘Groundbreaking’ Treatment for Pancreatic Cancer

A new treatment for pancreatic cancer is being tested out in clinical trials in several states, and one North Carolina doctor called it “groundbreaking.”

Lakewood Ranch Pancreatic Cancer Patient Receives New Treatment

A Lakewood Ranch retiree is one of the first patients in the country to receive an experimental treatment for pancreatic cancer through a trial offered at Sarasota Memorial Hospital.

RenovoCath is FDA-cleared for targeted delivery of chemotherapy to selected sites in the peripheral vascular system. The company is studying the use of RenovoCath-delivered gemcitabine for treatment of Locally Advanced Pancreatic Cancer (LAPC) in an ongoing clinical trial conducted under an IND.

Facebook-f X-twitter Linkedin-in Youtube

Menu

  • TAMP Therapy Platform
  • Our Science
  • RenovoCath®
  • Physicians
  • Evidence
  • Clinical Trials
  • Patients
  • The Procedure
  • FAQs
  • Patient Stories
  • Physician Locator
  • About
  • Leadership
  • Board of Directors
  • Advisory Boards
  • Contact
  • TAMP Therapy Platform
  • Our Science
  • RenovoCath®
  • Physicians
  • Evidence
  • Clinical Trials
  • Patients
  • The Procedure
  • FAQs
  • Patient Stories
  • Physician Locator
  • About
  • Leadership
  • Board of Directors
  • Advisory Boards
  • Contact
  • 2570 W. El Camino Real, Suite 640
    Mountain View, CA 94040
  • (650) 284-4433
  • info@renovorx.com
© 2026 RenovoRx®. All rights reserved.

Privacy Statement | Terms of Use